This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 4–6, 2024Stockholm, Sweden

Michelle Chen
CBO at Insilico Medicine


Michelle Chen is the Chief Business Officer at Insilico Medicine, a leader in the AI-powered drug discovery and development field.

She is responsible for the company’s strategies, business and corporate development, and the US operations. As a biotech executive, Michelle brings in 20+ years of experience in biopharma and technology industries, having worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies. She has a strong track record of success in company building, BD&L, M&A, R&D, marketing, and product commercialization.

Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received Bioinformatics training at Stanford.

Agenda Sessions

  • Pharma goes all in: the rise of artificial intelligence